Immunocore Holdings PLC

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Immunocore Holdings PLC had 452.68M in cash and cash equivalents.

Immunocore Holdings PLC reported 686.24M in total liabilities as of the latest reported quarter, including 246.70M in current liabilities and 439.54M in non-current liabilities.

As of the latest reported quarter, Immunocore Holdings PLC's total assets were 1.07B, consisting of 996.74M in current assets and 70.53M in non-current assets.

Immunocore Holdings PLC reported 381.03M in total shareholders' equity as of the latest reported quarter.